[关键词]
[摘要]
目的:探讨hsa_circ_0084927促进宫颈癌恶性生物学行为的作用机制。方法:通过高通量测序在宫颈癌组织中筛选获得高表达的hsa_circ_0084927,经生物信息学预测其互作miRNA,即miR?874?3p 和下游靶基因真核翻译起始因子4E结合蛋白1(EIF4EBP1)。采用RT?qPCR 检测hsa_circ_0084927、miR?874?3p 及EIF4EBP1 在宫颈癌组织和细胞系中的表达,并分析 hsa_circ_0084927表达水平与宫颈癌患者临床病理特征之间的关系。通过CCK?8实验、划痕愈合实验、Transwell侵袭实验及流式细胞术,评估敲低hsa_circ_0084927对HeLa和SiHa细胞增殖、迁移、侵袭能力及凋亡的影响。双萤光素酶报告基因实验、挽救实验检测hsa_circ_0084927与miR?874?3p,以及miR?874?3p与EIF4EBP1之间的靶向调控关系。结果:hsa_circ_0084927在宫颈癌组织中的表达显著高于配对的癌旁组织(P < 0.000 1)。与宫颈上皮永生化细胞H8 相比,宫颈癌HeLa 和SiHa 细胞中hsa_circ_ 0084927表达上调(均P < 0.000 1)。hsa_circ_0084927高表达组与低表达组在国际妇产科联盟(FIGO)分期方面差异具有统计学意义(P < 0.001)。敲低hsa_circ_0084927可显著抑制HeLa和SiHa细胞的增殖(均P < 0.000 1)、迁移(均P < 0.000 1)和侵袭能力 (均P < 0.05),并促进细胞凋亡(均P < 0.001)。双萤光素酶报告基因实验支持hsa_circ_0084927与miR?874?3p,以及miR?874?3p 与EIF4EBP1 之间存在靶向结合关系,挽救实验进一步提示该调控轴参与宫颈癌细胞增殖(均P < 0.05)。结论:hsa_circ_ 0084927可能通过miR?874?3p/EIF4EBP1轴促进宫颈癌细胞增殖,并参与宫颈癌恶性进展。
[Key word]
[Abstract]
Objective: To investigate the mechanism by which hsa_circ_0084927 promotes the malignant biological behaviors of cervical cancer. Methods: hsa_circ_0084927 was identified through high-throughput sequencing in cervical cancer tissues. Bioinformatics analysis was performed to predict its interacting miRNA, miR-874-3p, and the downstream target gene eukaryotic translation initiation factor 4E-binding protein 1 (EIF4EBP1). RT?qPCR was employed to measure the expression levels of hsa_circ_ 0084927, miR-874-3p, and EIF4EBP1 in cervical cancer tissues and cell lines, and the association between hsa_circ_0084927 expression and clinicopathological features was analyzed. Functional effects of hsa_circ_0084927 knockdown on proliferation, migration, invasion, and apoptosis in HeLa and SiHa cells were assessed using CCK-8, wound healing, Transwell invasion, and flow cytometry assays. The targeted regulatory relationships between hsa_circ_0084927 and miR-874-3p, as well as between miR-874-3p and EIF4EBP1, were validated by dual?luciferase reporter assays and rescue experiments. Results: hsa_circ_0084927 was significantly upregulated in cervical cancer tissues compared with paired adjacent non-tumor tissues (P < 0.000 1). Furthermore, compared with the immortalized cervical epithelial cell line H8, the expression of hsa_circ_0084927 was significantly upregulated in both HeLa and SiHa cervical cancer cell lines (all P < 0.000 1). The distribution of International Federation of Gynecology and Obstetrics (FIGO) stage (P < 0.001) between the hsa_circ_0084927 high-expression group and low-expression group was statistically significant. Knockdown of hsa_circ_0084927 markedly inhibited proliferation (all P < 0.000 1), migration (all P < 0.000 1), and invasion (all P < 0.05), while promoting apoptosis (all P < 0.001) compared with controls. Dual?luciferase reporter assays supported direct interactions between hsa_circ_0084927 and miR?874?3p and between miR?874?3p and EIF4EBP1; rescue experiments further indicated that this regulatory axis contributes to cervical cancer cell proliferation (all P < 0.05). Conclusion: hsa_circ_0084927 may promote cervical cancer cell proliferation through the miR-874-3p/EIF4EBP1 axis and thereby contribute to malignant progression.
[中图分类号]
[基金项目]
河南省医学科技攻关计划项目(LHGJ20240310)